Xeris Biopharma Holdings, Inc. financial data

Symbol
XERS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1375 West Fulton Street, Suite 1300, Chicago, Illinois
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 192 % -16.5%
Quick Ratio 46.1 % +44.7%
Debt-to-equity 85K % +15925%
Return On Equity -16.7K % -10837%
Return On Assets -19.6 % +19%
Operating Margin -26.3 % +51.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 148M shares +7.97%
Common Stock, Shares, Outstanding 148M shares +7.96%
Entity Public Float 362M USD +72.8%
Common Stock, Value, Issued 15K USD +7.14%
Weighted Average Number of Shares Outstanding, Basic 141M shares +2.46%
Weighted Average Number of Shares Outstanding, Diluted 141M shares +2.46%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 22.1M USD +169%
Revenue from Contract with Customer, Excluding Assessed Tax 171M USD +41.2%
Research and Development Expense 25.3M USD +29.5%
Operating Income (Loss) -45M USD +32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -63.5M USD +33.9%
Income Tax Expense (Benefit) -942K USD +7.28%
Net Income (Loss) Attributable to Parent -64.4M USD +17.2%
Earnings Per Share, Basic -0.47 USD/shares +17.5%
Earnings Per Share, Diluted -0.47 USD/shares +17.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 62.7M USD +23%
Accounts Receivable, after Allowance for Credit Loss, Current 37.4M USD +21.2%
Inventory, Net 40.9M USD +40.8%
Assets, Current 173M USD +4.69%
Property, Plant and Equipment, Net 5.78M USD -10.7%
Operating Lease, Right-of-Use Asset 23M USD +493%
Intangible Assets, Net (Excluding Goodwill) 107M USD -9.2%
Goodwill 22.9M USD 0%
Other Assets, Noncurrent 4.61M USD -2.43%
Assets 337M USD +4.75%
Accounts Payable, Current 7.09M USD -40.8%
Employee-related Liabilities, Current 10.4M USD +18.3%
Accrued Liabilities, Current 22.4M USD +11.1%
Liabilities, Current 73.1M USD -10.2%
Deferred Income Tax Liabilities, Net 2.58M USD -26.8%
Operating Lease, Liability, Noncurrent 34.4M USD +268%
Other Liabilities, Noncurrent 6.06M USD +19461%
Liabilities 346M USD +18.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -36K USD -24.1%
Retained Earnings (Accumulated Deficit) -636M USD -11.3%
Stockholders' Equity Attributable to Parent -9.18M USD -131%
Liabilities and Equity 337M USD +4.75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.3M USD +22.3%
Net Cash Provided by (Used in) Financing Activities 35.2M USD
Net Cash Provided by (Used in) Investing Activities -19.7M USD +55.3%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 148M shares +7.96%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.76M USD +93.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 66.9M USD +20.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.5M USD -84.7%
Deferred Tax Assets, Valuation Allowance 173M USD +8.94%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 18.2M USD +15723%
Operating Lease, Liability 39M USD +262%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -64.4M USD +17.2%
Lessee, Operating Lease, Liability, to be Paid 73.8M USD +290%
Property, Plant and Equipment, Gross 12.1M USD -1.86%
Operating Lease, Liability, Current 4.62M USD +219%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.23M USD +242%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.08M USD +291%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Deferred Income Tax Expense (Benefit) 307K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 34.8M USD +327%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.39M USD +242%
Deferred Tax Assets, Operating Loss Carryforwards 119M USD +6.91%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 694K USD -3.88%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.55M USD +241%
Operating Lease, Payments 1.54M USD -30%
Additional Paid in Capital 627M USD +4.19%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 4.89M USD +170%
Amortization of Intangible Assets 10.8M USD 0%
Depreciation, Depletion and Amortization 326K USD -10.4%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1.44M USD
Share-based Payment Arrangement, Expense 11.9M USD +4.34%
Operating Leases, Future Minimum Payments, Due in Three Years 6.08M USD +199%
Operating Leases, Future Minimum Payments Due 77.4M USD +255%
Interest Expense 27.4M USD +63.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%